Otsu, Japan

Meiko Jin

This inventor holds 1 USPTO granted patent. Top assignee: Takara Bio Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meiko Jin. Retrieved from https://idiyas.com/inventor/meiko-jin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meiko Jin: Innovator in Natural Killer Cell Production

Introduction

Meiko Jin is a prominent inventor based in Otsu, Japan. He has made significant contributions to the field of cellular biology, particularly in the production of natural killer cells. His innovative approach has the potential to impact various therapeutic applications.

Latest Patents

Meiko Jin holds a patent for a process for the production of natural killer cells. This process involves the expansion culture of a cell mass containing natural killer cells and/or cells capable of being differentiated into natural killer cells. It is characterized by the presence of a biological response modifier and cells that have been treated to lose their proliferation capability. This patent highlights his commitment to advancing medical science.

Career Highlights

Throughout his career, Meiko Jin has been associated with Takara Bio Inc., a company known for its focus on biotechnology and life sciences. His work has contributed to the development of innovative solutions in the field of cell therapy.

Collaborations

Meiko Jin has collaborated with notable colleagues, including Mitsuko Ideno and Mie Yabuuchi. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Meiko Jin's contributions to the production of natural killer cells exemplify his dedication to innovation in biotechnology. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…